Dr. Robert W. Malone

5Mind. The Meme Platform
Robert W. Malone, M.D., M.S.
Robert W. Malone, M.D., M.S.

Robert W. Malone is the discoverer of in-vitro and in-vivo RNA transfection and the inventor of mRNA vaccines, while he was at the Salk Institute in 1988. His research was continued at Vical in 1989, where the first in-vivo mammalian experiments were designed by him. The mRNA, constructs, reagents were developed at the Salk institute and Vical by Dr. Malone. The initial patent disclosures were written by Dr. Malone in 1988-1989. Dr. Malone was also an inventor of DNA vaccines in 1988 and 1989. This work results in over 10 patents and numerous publications, yielding about 7000 citations for this work. Dr. Malone was also an inventor of DNA vaccines in 1988 and 1989.

Dr. Malone has extensive research and development experience in the areas of pre-clinical discovery research, clinical trials, vaccines, gene therapy, bio-defense, and immunology. He has over twenty years of management and leadership experience in academia, pharmaceutical and biotechnology industries, as well as in governmental and non-governmental organizations.

Dr. Malone specializes in clinical research, medical affairs, regulatory affairs, project management, proposal management (large grants and contracts), vaccines and biodefense. This includes writing, developing, reviewing and managing vaccine, bio-threat and biologics clinical trials and clinical development strategies. He has been involved in developing, designing, and providing oversight of approximately forty phase 1 clinical trials and twenty phase 2 clinical trials, as well as five phase 3 clinical trials. He has served as medical director/medical monitor on approximately forty phase 1 clinical trials, and on twenty phase 2 clinical trials, including those run at vaccine-focused Clinical Research Organizations. His proposal development work has yielded clients billions of dollars.

Scientifically trained at UC Davis, UC San Diego, and at the Salk Institute Molecular Biology and Virology laboratories, Dr. Malone is an internationally recognized scientist (virology, immunology, molecular biology) and is known as one of the original inventors of mRNA vaccination and DNA Vaccination. His discoveries in mRNA non viral delivery systems are considered the key to the current COVID-19 vaccine strategies. Dr. Malone holds numerous fundamental domestic and foreign patents in the fields of gene delivery, delivery formulations, and vaccines.

He received his medical training at Northwestern University (MD) and Harvard University (Clinical Research Post Graduate) medical school, and in Pathology at UC Davis.

Dr. Malone has close to 100 peer-reviewed publications and published abstracts and has over 11,477 citations of his peer reviewed publications, as verified by Google Scholar.  His google scholar ranking is “outstanding” for impact factors. He has been an invited speaker at over 50 conferences, has chaired numerous conferences and he has sat on or served as chairperson on numerous NIAID and DoD study sections.

Visit Robert W. Malone’s Website at RWMalonemd.com

Robert W. Malone, MD, MS Full CV PDF

Robert-W-Malone-CV-July-2021

Contact Your Elected Officials
The Thinking Conservative
The Thinking Conservativehttps://www.thethinkingconservative.com/
The goal of THE THINKING CONSERVATIVE is to help us educate ourselves on conservative topics of importance to our freedom and our pursuit of happiness. We do this by sharing conservative opinions on all kinds of subjects, from all types of people, and all kinds of media, in a way that will challenge our perceptions and help us to make educated choices.

The Party Of Hate Is Unleashing Political Violence

Sec. Scott Bessent placed blame for violence against President Trump squarely on the Democrat Party who are “normalizing this violence. It’s got to stop.”

‘Radical Right’ Restore Britain: The Remigration Dream Machine?

There is nothing wrong with being white, male, or straight—you are not the problem. The issue lies in systems, not individuals, and flawed DEI policies.

Trump 2.0’s Grand Strategy Against China Is Slowly But Surely Coming Together

Casual observers think Trump acts without strategy, but Trump 2.0 is steadily executing a calculated plan aimed at countering China’s global rise.

From legacy to liability

"When the Washington Post cut a third of its shrinking staff, leaders called it 'strategic restructuring'—like calling an iceberg a 'necessary pivot.'!"

The SCOTUS Trump Tariff Test

There is an old expression that goes "If you're...

US Wins Its Record 11th Gold Medal at Winter Olympics

The U.S. Olympic team secured a record 11th Winter Games gold and could add another as men’s hockey faces Canada in the closing title final game.

Secret Service Agents Fatally Shoot Man Trying to Unlawfully Enter Mar-a-Lago

A man was shot and killed by Secret Service agents after allegedly trying to breach a secure perimeter at Trump’s Mar-a-Lago.

Documents Confirm JPMorgan Closed Trump’s Bank Accounts After Jan. 6 Capitol Breach

Court docs reveal JPMorgan Chase informed President Trump one month after the January 2021 U.S. Capitol breach it would close his accounts.

Trump Approves DC Emergency Declaration for Potomac Sewage Spill

President Trump approved an emergency declaration for the DC following a massive raw sewage spill into the Potomac River, the FEMA announced.

US Trade Representative Says Nations Are Not Backing Out of Tariff Deals

U.S. trading partners who made deals under Trump show no plans to exit, even after the Supreme Court struck down most of his tariffs.

DOJ Fires Interim US Attorney Hours After Virginia Court Selects Him

The DOJ announced it fired the interim U.S. attorney for the Eastern District of Virginia just hours after judges on the court made the appointment.

Trump Admin Says Courts Need to Act on Tariff Refunds After Supreme Court Ruling

The White House is awaiting court guidance on tariff refunds after the Supreme Court struck down several import levies last week.

Supreme Court Ruling on Tariffs Won’t Change US–China Trade Relations, Analysts

After the Supreme Court ruled Trump’s IEEPA tariffs unlawful, analysts say U.S.-China trade likely won’t change, as other legal levy options remain.
spot_img

Related Articles

Popular Categories

MAGA Business Central